TY - JOUR
T1 - Concern-driven integrated approaches to nanomaterial testing and assessment-report of the NanoSafety Cluster Working Group 10
AU - Oomen, Agnes G.
AU - Bos, Peter M.J.
AU - Fernandes, Teresa F.
AU - Hund-Rinke, Kerstin
AU - Boraschi, Diana
AU - Byrne, Hugh J.
AU - Aschberger, Karin
AU - Gottardo, Stefania
AU - Von Der Kammer, Frank
AU - Kühnel, Dana
AU - Hristozov, Danail
AU - Marcomini, Antonio
AU - Migliore, Lucia
AU - Scott-Fordsmand, Janeck
AU - Wick, Peter
AU - Landsiedel, Robert
N1 - Funding Information:
Hund-Rinke is an employee of the Fraunhofer Institute for Molecular Biology and Applied Ecology, IME, an institute of the Fraunhofer-Gesellschaft, a non-profit organisation performing applied research; she received funding of her nano-safety research from the EU (FP7), and the German government (BMBF, BMU). D. Boraschi is research director at the Italian National Research Council, the governmental institution of research; for research in nanoparticles she receives funding from the EU Commission (FP7), the Italian Government (MIUR) and a bank foundation (Fondazione Cariplo); she chairs the Immunosafety Task Force within the NanoSafety Cluster Working Group 2 – Hazard. H.J. Byrne is Head of the Focas Research Institute, Dublin Institute of Technology, Ireland. He has received support for research through the “Integrated NanoScience Platform for Ireland” (INSPIRE), funded by the Irish Government Platform for Research in Third Level Institutions, Cycle 4, and in part by the EU Structural Development Funds. K. Aschberger is employee and S. Gottardo a post-doctoral research fellow at the Joint Research Centre (JRC) of the European Commission. They both received funding for their nanosafety research from JRC and EU (FP7) projects. F. von der Kammer is employee of the University of Vienna. He receives funding for his nanosafety research from the Austrian Ministry for Education, the EU (FP7) and the Austrian Research Promotion Agency (FFG; Forschungsförderungsgesellschaft). D. Kühnel is an employee of UFZ, a research center within the Helmholtz-Association. She received funding from the EU (NanoValid, grant agreement no. 263147) and the German government (BMBF). L. Migliore is a full Professor in Medical Genetics of the University of Pisa; she received funding of her nanosafety research from the EU (FP7: NanoR-eTox No. CP-FP 214478-2 and Sanowork No. 280716) and the Italian Ministry of University, Research and Education. D. Hristozov and A. Marcomini are employees of the University of Venice, Italy; and J. Scott-Fordsmand of Aarhus University, Denmark. P. Wick is an employee of the Empa, Swiss Federal Laboratories for Materials Science and Technology, a national research institute of the ETH domain and is financed by Empa, Swiss government (SNSF) as well as the EU (FP7). R. Land-siedel is an employee of BASF SE, a chemical company producing and marketing nanomaterials; he received funding of his nanosafety research from BASF, EU (FP7), and the German government (BMBF). R. Landsiedel chaired the NanoSafety Cluster Working Group 10 without specific funding. Likewise all co-authors contributed to the NanoSafety Cluster Working Group 10 without specific funding. A detailed risk assessment strategy for nanomaterials is being developed within the FP7 project MARINA (Managing Risks of Nanoparticles). Input from the body of thought of MARINA was provided by Work Packages 12 and 13 chaired by A. Oomen and J. Scott-Fordsmand, respectively.
Funding Information:
A.G. Oomen and P.M.J. Bos are employees of the Dutch National Institute for Public Health and the Environment (RIVM); their contribution was funded by the EU FP7 project MARINA (grant agreement no. 263215) and the Dutch government. T.F. Fernandes is employee of the School of Life Sciences of the Heriot-Watt University, Edinburgh, UK. K.
PY - 2014/5
Y1 - 2014/5
N2 - Bringing together topic-related European Union (EU)-funded projects, the so-called "NanoSafety Cluster" aims at identifying key areas for further research on risk assessment procedures for nanomaterials (NM). The outcome of NanoSafety Cluster Working Group 10, this commentary presents a vision for concern-driven integrated approaches for the (eco-)toxicological testing and assessment (IATA) of NM. Such approaches should start out by determining concerns, i.e., specific information needs for a given NM based on realistic exposure scenarios. Recognised concerns can be addressed in a set of tiers using standardised protocols for NM preparation and testing. Tier 1 includes determining physico-chemical properties, non-testing (e.g., structure-activity relationships) and evaluating existing data. In tier 2, a limited set of in vitro and in vivo tests are performed that can either indicate that the risk of the specific concern is sufficiently known or indicate the need for further testing, including details for such testing. Ecotoxicological testing begins with representative test organisms followed by complex test systems. After each tier, it is evaluated whether the information gained permits assessing the safety of the NM so that further testing can be waived. By effectively exploiting all available information, IATA allow accelerating the risk assessment process and reducing testing costs and animal use (in line with the 3Rs principle implemented in EU Directive 2010/63/EU). Combining material properties, exposure, biokinetics and hazard data, information gained with IATA can be used to recognise groups of NM based upon similar modes of action. Grouping of substances in return should form integral part of the IATA themselves.
AB - Bringing together topic-related European Union (EU)-funded projects, the so-called "NanoSafety Cluster" aims at identifying key areas for further research on risk assessment procedures for nanomaterials (NM). The outcome of NanoSafety Cluster Working Group 10, this commentary presents a vision for concern-driven integrated approaches for the (eco-)toxicological testing and assessment (IATA) of NM. Such approaches should start out by determining concerns, i.e., specific information needs for a given NM based on realistic exposure scenarios. Recognised concerns can be addressed in a set of tiers using standardised protocols for NM preparation and testing. Tier 1 includes determining physico-chemical properties, non-testing (e.g., structure-activity relationships) and evaluating existing data. In tier 2, a limited set of in vitro and in vivo tests are performed that can either indicate that the risk of the specific concern is sufficiently known or indicate the need for further testing, including details for such testing. Ecotoxicological testing begins with representative test organisms followed by complex test systems. After each tier, it is evaluated whether the information gained permits assessing the safety of the NM so that further testing can be waived. By effectively exploiting all available information, IATA allow accelerating the risk assessment process and reducing testing costs and animal use (in line with the 3Rs principle implemented in EU Directive 2010/63/EU). Combining material properties, exposure, biokinetics and hazard data, information gained with IATA can be used to recognise groups of NM based upon similar modes of action. Grouping of substances in return should form integral part of the IATA themselves.
KW - 3Rs principle
KW - Environmental hazard assessment
KW - Grouping of substances
KW - Human health hazard assessment
KW - Nanotoxicology
UR - http://www.scopus.com/inward/record.url?scp=84890385124&partnerID=8YFLogxK
U2 - 10.3109/17435390.2013.802387
DO - 10.3109/17435390.2013.802387
M3 - Article
C2 - 23641967
AN - SCOPUS:84890385124
SN - 1743-5390
VL - 8
SP - 334
EP - 348
JO - Nanotoxicology
JF - Nanotoxicology
IS - 3
ER -